1/41
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Karl Landsteiner
He discovered the first human blood group system. First individual to perform FORWARD and REVERSE typing from drawing blood from himself and five associates (Stetson, Levinson, Fisher, Race, and Weiner).
Forward Typing
using known sources of commercial antisera (anti-A and anti-B) to detect antigens on an individual's RBC.
Anti A (color)
blue
Anti-B color
yellow
Sample in Forward Grouping
red cells
Reverse Typing
detecting ABO antibodies in the patient's serum by using known reagent RBCs
Sample in Reverse Typing
Serum
ABO Theory of Inheritance
Individual inherits 1 ABO gene from each parent and these 2 genes determine which ABO antigens are present on the RBC membrane
A and B antigens / genes
Autosomal Codominant genes
O phenotype / genes
Autosomal recessive
Amorph gene / silent gene
Location of ABO Gene
Chromosome 9 (formation of the ABO antigen)
Location of Fut 1 (H) gene
Chromosome 19 (formation of the ABO red cells)
Location of Fut 2 (Se) Gene
Chromosome 19 (formation of ABO on secretions)
A Genes and Immunodominant sugar
gene: a-3-N-Galactosaminyltransferase
immunodominant sugar: N-acetylgalactosamine
B Gene and Immunodominant sugar
gene: a-3-D-galactosyltransferase
immunodominant sugar: D-galactose
O Gene and Immunodominant sugar
gene: NONE (since amorph/ silent)
immunodominant sugar: L- fucose
H gene
transfer enzyme to transfer L-fucose to galactose terminal
immunodominant sugar of AB group
D-galactose and N-acetylgalactosamine
Number of H genes (highest to lowest amount of H)
O > A2 > B > A2B > A1 > A1B
A lectin
Dolichos biflorus
B lectin
Griffonia (Bandeiraea) simplicifolia
O Lectin
Ulex europaeus
Slide (Direct) Method Principle
Detection of A and B antigens on Erythrocyte Surface
Known and Unknown in Slide (Direct) Method
Known: Antibodies (Reagent)
Unknown: Antigen (RBC surface)
Reagents in Slide Method
Anti-A, Anti-B, Anti-AB
Tube (Direct) Method Principle
Traditional testing method to detect clinically significant antibodies
Principle of AHG Reagent (Coomb's Reagent)
Create a bridge between sensitized reagent RBCs, resulting in observable agglutination
Enhancement reagents
Added to the test system prior to 37C incubation phase to increase sensitivity and decrease zeta potential.
shortens incubation time
22% Bovine Albumin
gives positive ions
30-60 mins incubation
Low Ionic Strength Solution (LISS)
increases the uptake of antibody onto the RBC during sensitization phase
Polyethylene Glycol (PEG)
removes excess water
AHG reagent
added to the test system as it allows for agglutination of incomplete antibodies
Monospecific AHG reagent
contains only ONE antibody specificity, either anti-IgG or antibodies to complement components (C3 and C4 or C3b and C3d)
Polyspecific AHG
contains anti- IgG and anti-complement
not often used because it leads to the detection of clinically significant antibodies
Blood Type O
Universal red cell Donor and universal plasma receiver
No antigens
Antibodies: Anti-A and Anti- B
Blood Type AB
Universal red cell receiver and universal plasma donor
Antigens : A and B
Antibodies: none
Secretor genes
SeSe or Sese
Nonsecretor genes
sese
A blood type in secretors
A and H
B blood type in secretors
B and H
AB blood type in secretors
A, B and H
O blood type in secretors
H only (many concentrating factors)